Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients

Published: 23 February 2022| Version 1 | DOI: 10.17632/b323w45vm2.1
Contributor:
maria picchio

Description

This dataset was used in the paper "Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients" published by Diagnostics in 2021 (doi.org/10.3390/diagnostics11112068). In this work we compared the performance of 68Ga-PSMA, 68Ga-DOTA-RM2 and MRI for the staging of PCa. All quantitative analysis can be reproduced by reading this dataset.

Files

Institutions

  • Ospedale San Raffaele

Categories

Positron Emission Tomography, Magnetic Resonance Imaging, Prostate Cancer

Licence